Stavudine (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Stavudine drug offered from KAISER FOUNDATION HOSPITALS. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Stavudine
SUBSTANCE NAME: STAVUDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-01-27
END MARKETING DATE: 0000-00-00


Stavudine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionStavudine from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/1)
START MARKETING DATE: 2010-01-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0028_0c80436e-c57d-4cf7-afb4-a3d70e4fb5d4
PRODUCT NDC: 0179-0028
APPLICATION NUMBER: ANDA078957

Other STAVUDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedStavudine
Camber Pharmaceuticals, Inc.Stavudine
Cipla Ltd.stavudine
Citron Pharma LLCStavudine
E.R. Squibb & Sons, L.L.C.ZERIT
KAISER FOUNDATION HOSPITALSStavudine
Mylan Pharmaceuticals Inc.Stavudine
Rising Pharmaceuticals, Inc.Stavudine
State of Florida DOH Central PharmacyZERIT